Legend Biotech Corp SEC filings LEGN

Legend Biotech Corp has 386 filings in SEC EDGAR's recent list, going back to Mar 9, 2020. Its latest annual report, Form 20-F, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 4, 2026. The company's fiscal year ends on December 31.

Legend Biotech Corp SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2026 —
6-K Current report (foreign issuer) Nov 4, 2026 Nov 3, 2026
6-K Current report (foreign issuer) Oct 15, 2026 Oct 15, 2026
6-K Current report (foreign issuer) Oct 13, 2026 Oct 13, 2026
S-8 Employee stock plan registration Oct 7, 2026 —
4 Insider transaction Oct 1, 2026 Sep 29, 2026
144 Notice of proposed sale Sep 29, 2026 —
4 Insider transaction Sep 28, 2026 Sep 24, 2026
4 Insider transaction Sep 28, 2026 Sep 24, 2026
4 Insider transaction Sep 28, 2026 Sep 24, 2026
4 Insider transaction Sep 28, 2026 Sep 24, 2026
4 Insider transaction Sep 28, 2026 Sep 24, 2026
4 Insider transaction Sep 28, 2026 Sep 24, 2026
6-K Current report (foreign issuer) Sep 25, 2026 Sep 24, 2026
6-K Current report (foreign issuer) Sep 24, 2026 Sep 24, 2026
4 Insider transaction Sep 23, 2026 Sep 21, 2026
144 Notice of proposed sale Sep 22, 2026 —
144 Notice of proposed sale Sep 22, 2026 —
4 Insider transaction Sep 16, 2026 Sep 15, 2026
3 Initial insider ownership Sep 16, 2026 Sep 15, 2026
6-K Current report (foreign issuer) Sep 15, 2026 Sep 15, 2026
6-K Current report (foreign issuer) Sep 14, 2026 Sep 14, 2026
4 Insider transaction Aug 18, 2026 Aug 14, 2026
6-K Current report (foreign issuer) Aug 18, 2026 Aug 18, 2026
6-K Current report (foreign issuer) Aug 11, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Aug 6, 2026 Aug 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2026 —
3 Initial insider ownership Aug 3, 2026 Jul 24, 2026
6-K Current report (foreign issuer) Jul 27, 2026 Jul 27, 2026
6-K Current report (foreign issuer) Jul 15, 2026 Jul 15, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
144 Notice of proposed sale Jun 30, 2026 —
4 Insider transaction Jun 29, 2026 Jun 25, 2026
144 Notice of proposed sale Jun 26, 2026 —
6-K Current report (foreign issuer) Jun 22, 2026 Jun 22, 2026
424B5 Prospectus supplement Jun 18, 2026 —
424B5 Prospectus supplement Jun 17, 2026 —
F-6EF Filing Jun 17, 2026 —
6-K Current report (foreign issuer) Jun 15, 2026 Jun 15, 2026
6-K Current report (foreign issuer) Jun 2, 2026 Jun 2, 2026
6-K Current report (foreign issuer) Jun 1, 2026 Jun 1, 2026
6-K Current report (foreign issuer) May 21, 2026 May 21, 2026
6-K Current report (foreign issuer) May 12, 2026 Mar 31, 2026
6-K Current report (foreign issuer) Apr 14, 2026 Apr 14, 2026
4 Insider transaction Mar 27, 2026 Mar 25, 2026
144 Notice of proposed sale Mar 26, 2026 —
144 Notice of proposed sale Mar 26, 2026 —
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
20-F Annual report (foreign issuer) Mar 10, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Mar 10, 2026 Mar 10, 2026
6-K Current report (foreign issuer) Feb 6, 2026 Feb 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2026 —
6-K Current report (foreign issuer) Jan 23, 2026 Jan 23, 2026
6-K Current report (foreign issuer) Jan 21, 2026 Jan 21, 2026
6-K Current report (foreign issuer) Jan 14, 2026 Jan 14, 2026
6-K Current report (foreign issuer) Jan 12, 2026 Jan 12, 2026
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 29, 2025 —
6-K Current report (foreign issuer) Dec 8, 2025 Dec 8, 2025
144 Notice of proposed sale Nov 17, 2025 —
6-K Current report (foreign issuer) Nov 12, 2025 Sep 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2025 —
6-K Current report (foreign issuer) Nov 3, 2025 Nov 3, 2025
6-K Current report (foreign issuer) Oct 14, 2025 Oct 10, 2025
6-K Current report (foreign issuer) Oct 14, 2025 Oct 14, 2025
6-K Current report (foreign issuer) Oct 7, 2025 Oct 7, 2025
144 Notice of proposed sale Sep 26, 2025 —
144 Notice of proposed sale Sep 24, 2025 —
144 Notice of proposed sale Sep 23, 2025 —
144 Notice of proposed sale Sep 23, 2025 —
144 Notice of proposed sale Sep 23, 2025 —
6-K Current report (foreign issuer) Aug 18, 2025 Aug 18, 2025
6-K Current report (foreign issuer) Aug 11, 2025 Jun 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2025 —
144 Notice of proposed sale Jul 23, 2025 —
144 Notice of proposed sale Jul 23, 2025 —
6-K Current report (foreign issuer) Jul 16, 2025 Jul 16, 2025
6-K Current report (foreign issuer) Jun 30, 2025 Jun 30, 2025
144 Notice of proposed sale Jun 26, 2025 —
144 Notice of proposed sale Jun 25, 2025 —
144 Notice of proposed sale Jun 24, 2025 —
144 Notice of proposed sale Jun 24, 2025 —
6-K Current report (foreign issuer) Jun 12, 2025 Jun 12, 2025
6-K Current report (foreign issuer) Jun 6, 2025 Jun 6, 2025
144 Notice of proposed sale Jun 6, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 6, 2025 —
6-K Current report (foreign issuer) Jun 5, 2025 Jun 5, 2025
6-K Current report (foreign issuer) Jun 3, 2025 Jun 3, 2025
6-K Current report (foreign issuer) May 23, 2025 May 22, 2025
6-K Current report (foreign issuer) May 14, 2025 May 14, 2025
6-K Current report (foreign issuer) May 13, 2025 Mar 31, 2025
6-K Current report (foreign issuer) May 12, 2025 May 12, 2025
144 Notice of proposed sale May 1, 2025 —
6-K Current report (foreign issuer) Apr 15, 2025 Apr 15, 2025
144 Notice of proposed sale Mar 25, 2025 —
144 Notice of proposed sale Mar 25, 2025 —
144 Notice of proposed sale Mar 25, 2025 —
144 Notice of proposed sale Mar 13, 2025 —
20-F Annual report (foreign issuer) Mar 11, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Mar 11, 2025 Mar 11, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
6-K Current report (foreign issuer) Jan 22, 2025 Jan 22, 2025
6-K Current report (foreign issuer) Jan 14, 2025 Jan 14, 2025
144 Notice of proposed sale Jan 10, 2025 —
144 Notice of proposed sale Dec 26, 2024 —
144 Notice of proposed sale Dec 26, 2024 —
6-K Current report (foreign issuer) Dec 23, 2024 Dec 23, 2024
6-K Current report (foreign issuer) Dec 10, 2024 Dec 9, 2024
144 Notice of proposed sale Dec 2, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
S-8 Employee stock plan registration Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
6-K Current report (foreign issuer) Nov 12, 2024 Sep 30, 2024
6-K Current report (foreign issuer) Nov 5, 2024 Nov 4, 2024
6-K Current report (foreign issuer) Oct 22, 2024 Oct 22, 2024
6-K Current report (foreign issuer) Oct 21, 2024 Oct 21, 2024
6-K Current report (foreign issuer) Oct 15, 2024 Oct 15, 2024
6-K Current report (foreign issuer) Sep 27, 2024 Sep 27, 2024
144 Notice of proposed sale Sep 25, 2024 —
144 Notice of proposed sale Sep 20, 2024 —
144 Notice of proposed sale Sep 20, 2024 —
6-K Current report (foreign issuer) Sep 20, 2024 Sep 20, 2024
UPLOAD Letter from the SEC Sep 16, 2024 —
CORRESP Letter to the SEC Sep 11, 2024 —
UPLOAD Letter from the SEC Sep 4, 2024 —
6-K Current report (foreign issuer) Aug 27, 2024 Aug 27, 2024
6-K Current report (foreign issuer) Aug 9, 2024 Jun 30, 2024
6-K Current report (foreign issuer) Aug 8, 2024 Aug 8, 2024
6-K Current report (foreign issuer) Jul 26, 2024 Jul 26, 2024
6-K Current report (foreign issuer) Jul 17, 2024 Jul 17, 2024
6-K Current report (foreign issuer) Jul 2, 2024 Jul 2, 2024
144 Notice of proposed sale Jun 25, 2024 —
144 Notice of proposed sale Jun 25, 2024 —
6-K Current report (foreign issuer) Jun 3, 2024 Jun 3, 2024
6-K Current report (foreign issuer) May 23, 2024 May 23, 2024
6-K Current report (foreign issuer) May 13, 2024 Mar 31, 2024
6-K Current report (foreign issuer) Apr 22, 2024 Apr 22, 2024
6-K Current report (foreign issuer) Apr 16, 2024 Apr 16, 2024
6-K Current report (foreign issuer) Apr 8, 2024 Apr 5, 2024
SC 13G/A Amended ownership over 5% (passive) Apr 5, 2024 —
6-K Current report (foreign issuer) Mar 29, 2024 Mar 29, 2024
144 Notice of proposed sale Mar 28, 2024 —
144 Notice of proposed sale Mar 27, 2024 —
144 Notice of proposed sale Mar 26, 2024 —
144 Notice of proposed sale Mar 25, 2024 —
144 Notice of proposed sale Mar 25, 2024 —
144 Notice of proposed sale Mar 19, 2024 —
F-3ASR Filing Mar 19, 2024 —
20-F Annual report (foreign issuer) Mar 19, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Mar 15, 2024 Mar 15, 2024
6-K Current report (foreign issuer) Mar 13, 2024 Mar 13, 2024
6-K Current report (foreign issuer) Mar 11, 2024 Dec 31, 2023
144/A Filing Feb 28, 2024 —
144 Notice of proposed sale Feb 28, 2024 —
144 Notice of proposed sale Feb 27, 2024 —
144 Notice of proposed sale Feb 23, 2024 —
6-K Current report (foreign issuer) Feb 23, 2024 Feb 22, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G Ownership over 5% (passive) Jan 29, 2024 —
6-K Current report (foreign issuer) Jan 23, 2024 Jan 23, 2024
6-K Current report (foreign issuer) Jan 23, 2024 Jan 23, 2024
6-K Current report (foreign issuer) Jan 9, 2024 Jan 9, 2024
144 Notice of proposed sale Dec 27, 2023 —
144 Notice of proposed sale Dec 22, 2023 —
144 Notice of proposed sale Dec 22, 2023 —
6-K Current report (foreign issuer) Dec 21, 2023 Dec 21, 2023
6-K Current report (foreign issuer) Dec 21, 2023 Dec 21, 2023
144 Notice of proposed sale Dec 12, 2023 —
6-K Current report (foreign issuer) Dec 12, 2023 Dec 11, 2023
6-K Current report (foreign issuer) Nov 20, 2023 Sep 30, 2023
6-K Current report (foreign issuer) Nov 13, 2023 Nov 13, 2023
144/A Filing Oct 17, 2023 —
144 Notice of proposed sale Oct 17, 2023 —
6-K Current report (foreign issuer) Oct 17, 2023 Oct 17, 2023
144 Notice of proposed sale Oct 16, 2023 —
144 Notice of proposed sale Sep 27, 2023 —
6-K Current report (foreign issuer) Sep 25, 2023 Sep 25, 2023
144 Notice of proposed sale Sep 22, 2023 —
144 Notice of proposed sale Sep 22, 2023 —
144 Notice of proposed sale Sep 18, 2023 —
UPLOAD Letter from the SEC Sep 15, 2023 —
CORRESP Letter to the SEC Sep 8, 2023 —
UPLOAD Letter from the SEC Aug 31, 2023 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LEGN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
Somerset, NJ
SEC filer status
Large accelerated filer
SEC CIK
1801198

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.